Shandong Shanda Wit Science and Technology Co., Ltd. (000915.SZ)

CNY 25.14

(-1.8%)

Market Cap (In CNY)

5.89 Billion

Revenue (In CNY)

2.48 Billion

Net Income (In CNY)

585.26 Million

Avg. Volume

6.92 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
23.61-37.08
PE
12.46
EPS
2.09
Beta Value
0.195
ISIN
CNE000000Z28
CUSIP
-
CIK
-
Shares
234331000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ms. Jie Yang
Employee Count
-
Website
https://www.sd-wit.com
Ipo Date
1999-06-09
Details
Shandong Shanda Wit Science and Technology Co., Ltd. engages in the pharmaceutical and environment protection businesses in China. Its medical products include azithromycin granules, glycyrrhiza zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gums, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company offers environmental products, including deep disc filters, sulfuric acid diluents, industrial wastewater treatment solutions, chlorine dioxide generators, chlorine dioxide purifiers, and flue gas desulfurization and denitrification emission technology, as well as plans and constructs artificial wetland. Its environmental products also comprise optional equipment and raw materials; chlorine dioxide disinfectants, compounds, and composites; waste gas treatment; and solid waste treatment. The company also provides information products, such as DLP splicing display units, LCD splicing display units, image stitching processors, industrial automation control products, and communication products; and crystal products. In addition, it is involved in the provision of education services. The company was founded in 1993 and is based in Jinan, China.